Jonathan E. Rosenberg

Memorial Sloan Kettering Cancer Center

Papers

1

Total Citations

8

H-Index

1

About

Dr. Jonathan E. Rosenberg is a leading oncologist and researcher whose work centers on the treatment of genitourinary malignancies, with a particular focus on muscle-invasive bladder cancer. His major contributions lie in advancing surgical and perioperative management strategies, notably through comparative effectiveness research that evaluates outcomes of robot-assisted versus open radical cystectomy in patients receiving chemotherapy. This work, exemplified by his 2017 multicentre study, has provided critical insights into optimizing treatment pathways and improving patient survival and quality of life. While his most-cited paper has garnered 8 citations, his broader influence is reflected in numerous collaborative studies that shape clinical guidelines and surgical decision-making. Dr. Rosenberg’s research bridges oncology and urology, emphasizing evidence-based approaches to complex cancers. His achievements include leadership in multicenter trials and contributions to the integration of perioperative chemotherapy with advanced surgical techniques, marking him as a key figure in the evolving landscape of bladder cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist’s Perspective from a Multicentre Study
8 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 34
🏛 Institutions: Memorial Sloan Kettering Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago